- Home
- MDXG vs XIFR Comparison
MDXG vs XIFR Comparison
Compare MDXG & XIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- XIFR
- Stock Information
- Founded
- MDXG 2006
- XIFR 2014
- Country
- MDXG United States
- XIFR United States
- Employees
- MDXG N/A
- XIFR N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- XIFR
- Sector
- MDXG Health Care
- XIFR
- Exchange
- MDXG Nasdaq
- XIFR NYSE
- Market Cap
- MDXG 999.9M
- XIFR 815.0M
- IPO Year
- MDXG N/A
- XIFR N/A
- Fundamental
- Price
- MDXG $5.81
- XIFR $8.21
- Analyst Decision
- MDXG Strong Buy
- XIFR Sell
- Analyst Count
- MDXG 2
- XIFR 3
- Target Price
- MDXG $12.50
- XIFR $9.00
- AVG Volume (30 Days)
- MDXG 505.5K
- XIFR 954.1K
- Earning Date
- MDXG 07-30-2025
- XIFR 07-23-2025
- Dividend Yield
- MDXG N/A
- XIFR 22.20%
- EPS Growth
- MDXG N/A
- XIFR N/A
- EPS
- MDXG 0.27
- XIFR N/A
- Revenue
- MDXG $352,375,000.00
- XIFR $1,255,000,000.00
- Revenue This Year
- MDXG $9.55
- XIFR $11.14
- Revenue Next Year
- MDXG $11.43
- XIFR $2.34
- P/E Ratio
- MDXG $21.73
- XIFR N/A
- Revenue Growth
- MDXG 5.34
- XIFR 15.14
- 52 Week Low
- MDXG $5.47
- XIFR $7.53
- 52 Week High
- MDXG $10.14
- XIFR $29.03
- Technical
- Relative Strength Index (RSI)
- MDXG 30.41
- XIFR N/A
- Support Level
- MDXG $5.80
- XIFR N/A
- Resistance Level
- MDXG $6.03
- XIFR N/A
- Average True Range (ATR)
- MDXG 0.19
- XIFR 0.00
- MACD
- MDXG -0.05
- XIFR 0.00
- Stochastic Oscillator
- MDXG 2.47
- XIFR 0.00
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About XIFR XPLR INFRASTRUCTURE LP
XPLR Infrastructure LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.